BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26512967)

  • 1. Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid Leukemia.
    Bartholomae S; Gruhn B; Debatin KM; Zimmermann M; Creutzig U; Reinhardt D; Steinbach D
    Pediatr Blood Cancer; 2016 Feb; 63(2):242-7. PubMed ID: 26512967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia.
    Steinbach D; Gillet JP; Sauerbrey A; Gruhn B; Dawczynski K; Bertholet V; de Longueville F; Zintl F; Remacle J; Efferth T
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4357-63. PubMed ID: 16857811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia.
    Steinbach D; Sell W; Voigt A; Hermann J; Zintl F; Sauerbrey A
    Leukemia; 2002 Aug; 16(8):1443-7. PubMed ID: 12145683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
    Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
    J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers.
    Varatharajan S; Abraham A; Karathedath S; Ganesan S; Lakshmi KM; Arthur N; Srivastava VM; George B; Srivastava A; Mathews V; Balasubramanian P
    Pharmacogenomics; 2017 Feb; 18(3):235-244. PubMed ID: 28112576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of ATP binding cassette transporters is associated with poor prognosis in acute myeloid leukemia.
    Liu B; Li LJ; Gong X; Zhang W; Zhang H; Zhao L
    Oncol Lett; 2018 May; 15(5):6671-6677. PubMed ID: 29616130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABC transporters are predictors of treatment failure in acute myeloid leukaemia.
    Cerovska E; Salek C; Kundrat D; Sestakova S; Pesek A; Brozinova I; Belickova M; Remesova H
    Biomed Pharmacother; 2024 Jan; 170():115930. PubMed ID: 38039756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death.
    Cortez MA; Scrideli CA; Yunes JA; Valera ET; Toledo SR; Pavoni-Ferreira PC; Lee ML; Petrilli AS; Brandalise SR; Tone LG
    Pediatr Blood Cancer; 2009 Dec; 53(6):996-1004. PubMed ID: 19672972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
    Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Rojas L; Martínez-Cuadrón D; Hervás D; Boluda B; García-Robles A; Rodríguez-Veiga R; Martín-Cerezuela M; Cervera J; Sendra L; Sanz J; Miguel A; Lorenzo I; Poveda JL; Sanz MÁ; Aliño SF
    Leuk Lymphoma; 2017 May; 58(5):1197-1206. PubMed ID: 27701910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia.
    Kim HP; Bernard L; Berkowitz J; Nitta J; Hogge DE
    Cytometry B Clin Cytom; 2012 Sep; 82(5):283-94. PubMed ID: 22508650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
    Ho MM; Hogge DE; Ling V
    Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.
    Damiani D; Tiribelli M; Geromin A; Michelutti A; Cavallin M; Sperotto A; Fanin R
    Am J Hematol; 2015 Sep; 90(9):784-9. PubMed ID: 26059733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia.
    Steinbach D; Lengemann J; Voigt A; Hermann J; Zintl F; Sauerbrey A
    Clin Cancer Res; 2003 Mar; 9(3):1083-6. PubMed ID: 12631611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
    J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-Binding Cassette transporters' gene expression in pediatric patients with acute leukemia; a comprehensive analysis of published reports through PubMed search engine.
    Mehrvar N; Akbari ME; Rezvany MR; Abolghasemi H; Saberynejad J; Mehrvar A; Faranoush M; Keramatinia AA; Shekarriz-Foumani R; Movafagh A
    Cell Mol Biol (Noisy-le-grand); 2019 Feb; 65(2):7-13. PubMed ID: 30860475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
    van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
    Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.
    Benderra Z; Faussat AM; Sayada L; Perrot JY; Chaoui D; Marie JP; Legrand O
    Clin Cancer Res; 2004 Dec; 10(23):7896-902. PubMed ID: 15585622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.
    van den Heuvel-Eibrink MM; van der Holt B; Burnett AK; Knauf WU; Fey MF; Verhoef GE; Vellenga E; Ossenkoppele GJ; Löwenberg B; Sonneveld P
    Ann Hematol; 2007 May; 86(5):329-37. PubMed ID: 17340137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.